The article discusses causation and apportionment issues in opioid lawsuits by examining the Oklahoma trial court judge's 2019 ruling against Johnson & Johnson and subsidiary Janssen Pharmaceuticals. Also cited are the issue of market share liability in mass tort cases, and whether it is right to hold a defendant liable for the cost of addressing a social problem that is also caused by other actors.